Company Filing History:
Years Active: 2010-2014
Title: Naomi Laing: Innovator in Targeted Binding Agents
Introduction
Naomi Laing is a prominent inventor based in Waltham, MA (US), known for her significant contributions to the field of targeted binding agents. With a total of 4 patents, her work focuses on developing innovative solutions for medical diagnostics and treatments.
Latest Patents
Laing's latest patents include groundbreaking inventions such as "Targeted binding agents directed to PDGRF-alpha and uses thereof." This invention discloses fully human monoclonal antibodies directed to the antigen PDGFR-alpha, which are useful for diagnosing and treating diseases associated with the activity and/or overexpression of PDGFR-alpha. Another notable patent is "Targeted binding agents directed to sonic hedgehog homolog and uses thereof." This invention relates to fully human monoclonal antibodies directed to human sonic hedgehog homolog (Shh), which are beneficial in treating diseases linked to the activity and/or overproduction of Shh.
Career Highlights
Throughout her career, Naomi Laing has worked with esteemed companies such as MedImmune Limited and AstraZeneca. Her experience in these organizations has contributed to her expertise in the development of targeted therapies.
Collaborations
Laing has collaborated with notable professionals in her field, including Jaspal Singh Kang and Ian Nevin Foltz. These collaborations have further enhanced her research and innovation efforts.
Conclusion
Naomi Laing's contributions to the field of targeted binding agents demonstrate her commitment to advancing medical science. Her innovative patents and collaborations highlight her role as a leading inventor in this important area of research.